Skip to content

Cardiovascular Fitness of Patients With Multiple Sclerosis, Effect of Exercise on Fatigue and Depression

Cardiovascular Fitness and the Influence of a Controlled Combined Exercise Program on Fatigue and Depression of Newly Diagnosed Patients With Multiple Sclerosis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05671588
Enrollment
70
Registered
2023-01-04
Start date
2022-05-01
Completion date
2025-12-31
Last updated
2024-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple Sclerosis, Controlled combined exercise, Cardiovascular fitness, Fatigue, Depression

Brief summary

This study is focused on patients with multiple sclerosis (MS), their cardiovascular fitness, and the effect of combined controlled training on the perception of fatigue, the development of depression, and quality of life in the first year after diagnosis.

Detailed description

The main goal is to find out if fatigue, depression, and quality of life depend on the type of training as well as controlled management of newly diagnosed patients. Fatigue is one of the frequent disabling symptoms and the most difficult to influence pharmacologically. It could lead to inactivity and the progression of deconditioning. We know from systematic reviews that aerobic activity leads to improvement in fatigue, however, there are also opinions about exercise intolerance due to disruption of cardiac autonomy control. The investigators will try to determine whether early rehabilitation intervention leads to support and motivation of patients with an incurable chronic neurodegenerative disease to improve the patient condition and contentment. The researchers will focus on effective training by comparing the study group with a control group of patients undergoing conventional rehabilitation versus a protocol-defined controlled combined (aerobic-resistant) exercise program - based on the results of spiroergometry. Both groups will be treated at ambulatory sections by protocol-defined rehabilitation for a 1-hour duration, twice a week for one month, and once a week for the next month (12 therapies in total). The control group will be educated in exercises according to kinesiological analysis to do regularly at home. Finally, the researchers will see if early intervention leads to a change in the active approach of probands.

Interventions

PROCEDUREConventional rehabilitation

Patients will undergo conventional rehabilitation.

PROCEDUREControlled combined exercise group

Patients will undergo protocol-defined combined aerobic-resistant therapy on a cycling ergometer and multifunctional fitness device

Sponsors

University Hospital Ostrava
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

All participants of the study will undergo a clinical examination including a questionnaire survey and spiroergometry - examiners will not have access to intervention documents before and after the intervention (period of 6 months), as well as examiners will not perform the therapy.

Intervention model description

The study subjects will be enrolled into two parallel groups.

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Age 20 - 45 years * Newly diagnosed patients with multiple sclerosis * Relapsing-remitting MS (RRMS) or clinically isolated syndrome (CIS) * EDSS 0-6 * Signed informed consent

Exclusion criteria

* Progressive forms of MS (PRMS or SPMS), Malignant MS * Non-cooperation, disagreement with the study * Contraindication to spiroergometry

Design outcomes

Primary

MeasureTime frameDescription
Power to weight ratio (W.kg-1)6 monthsChange after six months follow up in conventional, experimental and control group
Maximal aerobic capacity (VO2max.kg-1)6 monthsChange after six months follow up in conventional, experimental and control group

Secondary

MeasureTime frameDescription
Symptom-Checklist-90-Standard (SCL-90-S)6 monthsChange in result of percentile score
Beck Depression Inventory Score II (BDI II)6 monthsSelf-reported rating inventory that measures characteristic attitudes and symptoms of depression, 0-13 - minimal or none depression, 29-63 - severe depression
36-Item Short Form Survey (SF-36)6 monthsSelf-reported measure of health-related quality of life, minimum 0 points, maximum 100 points - the higher score is the sign of better quality of life
Heart rate variability (ms)6 monthsChange after six months follow up in conventional, experimental and control group
Body composition analysis %)6 monthsBody composition (fat, water, muscle, bone mass) analysis will be performed in study subjects and expressed as per cent.
Maximal heart rate (bpm)6 monthsChange after six months follow up in conventional, experimental and control group
Modified Fatigue Impact Scale (MFIS)6 monthsSelf-reported measure of level of fatigue, minimum 0 points, maximum 84 points - the less score means less fatigue

Other

MeasureTime frameDescription
Cost-benefit analysis of early rehabilitation intervention (CZK)6 monthsCost-benefit analysis of early rehabilitation intervention will be performed and expressed as the price in Czech crowns (CZK).

Countries

Czechia

Contacts

Primary ContactJiří Hynčica
jiri.hyncica@fno.cz0042059737

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026